Mark G. Currie, Chief Scientific Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 130,000 shares at $18.51 ($2.4M) on 2018-08-22, disclosed to the SEC on 2018-08-24.
Open-market sale of $2.4M IRWD by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.51 | 65,000 | $1.2M | 50.2% |
| 2 | $18.39 | 65,000 | $1.2M | 49.8% |
| Total | $18.45 avg | 130,000 | $2.4M | 100% |
| Filing → |
| IRWD | SELL | 2021-06-16 | $546K | — | Filing → |
| CYCN | SELL | 2020-12-30 | $121K | — | Filing → |
| IRWD | SELL | 2020-01-24 | $755K | — | Filing → |